First introduced in 1985 as a new method of non-invasive brain stimulation, transcranial magnetic stimulation ( TMS) is a method that involves placing a small coil over the scalp, and rapid alternating current is passed through the coil wire, producing a magnetic field that passes through the brain unimpeded. Next, this approach was used to test conduction of the nerves. Note was impelled in the use of transcranial magnetic stimulation for depression by the development of an apparatus that could deliver quick, repetitive stimulation. Unlike electroconvulsive therapy, transcranial magnetic stimulation for depression does not require anesthesia, and does not cause a seizure. In particular, initial research indicated that prefrontal cortex transcranial magnetic stimulation was related to antidepressant features. Learn more by visiting TMS Therapy near me.
Actually, only devices for transcranial magnetic stimulation have earned US clearance. Food and Drug Administration ( FDA) has received no FDA consent for transcranial magnetic brain stimulation as a healing method for analytical uses. One system, the NeoPulse (Neuronetic, Atlanta GA) has been licensed as a depression therapy in Canada and Israel.
Brain TMS is considered investigational as treating, but not limited to, all psychological disorders including depression. On its published literature, transcranial magnetic stimulation for depression or other mood disorders consists of small controlled trials with minimal follow-up, containing specific patient population, stimulation parameters and location of stimulus. While some trials of transcranial magnetic stimulation for depression show the efficacy of this treatment method, others do not find much benefit.
A new research from the University of Bonn, recently published in the British Journal of Psychiatry, shows that repeated transcranial magnetic stimulation for depression (rTMS) provides almost the same reduction in symptoms of depression as electroconvulsive therapy (ECT), but with no side effects on the memory or other cognitive drawbacks that ECT has.
However, the researchers warn that their conclusion may not be entirely reliable due to the small sample size of only thirty patients engaged in the study, and the separation of patient groups was not made on a random basis. This new discovery on memory side effects is very promising, however, with other investigations also having meant that rTMS can improve the mood of sufferers with depression.
Treatment such as psychotherapy or medication , or a combination of both, may be beneficial in helping to relieve the symptoms for a lot of people with severe depression. Nonetheless, symptoms are so severe for around one in twenty sufferers from depression that none of these solutions work for them, and they are searching for more successful therapies.